A venture fund run by scientists, backing the researchers and founders solving the hardest problems in human health — from the earliest possible stage.
Founded by researchers out of Stanford's Department of Genetics and directors of the Stanford Healthcare Innovation Lab, Arben Ventures has unique access to the research ecosystem ranked #1 in the world for genomics and leading in precision medicine, longevity, multi-omics, and wearables.
PhDs manage due diligence and support our portfolio teams as they launch, scale, and grow — every step of the way. We invest in areas where we see the most potential for disruption and where our partners have expertise.
In 2023, Arben Ventures was born from a shared conviction: too many transformative ideas fail to make it out of the lab. They're too far along for academic support but too early for top VCs. We bridge that gap.
We write $25–50K initial checks under $12M valuation, and up to $500K follow-on for our portfolio of pre-seed and seed stage health startups. Our mission is to accelerate the technologies that will make millions of people healthier.
We invest where converging breakthroughs in genomics, multi-omics, wearables, and AI are creating transformational opportunities in human health.
Our engagement goes far beyond capital. We're in the trenches with founders every week.
Our founders carry genetic risk factors, survived cancer, and built this fund because they couldn't not. Authenticity is our strongest signal.

Cornell Nutrition PhD. Stanford Genetics Postdoc. Co-founded the Stanford Mental Healthcare Innovations Summit. 20+ peer-reviewed publications, 1,887 citations. Published in Nature Medicine. Raised >$15M in philanthropic and venture capital.
Survivor of breast and thyroid cancer — it's personal.

Co-founded the Stanford Healthcare Innovation Lab (>$500M in startup value). Raised >$20M in philanthropy. 5.9x angel track record. Founded 3 startups, Enovone to $3M revenue in 16 months. 19,000+ relationship network.
Has APOE4, a major risk factor for Alzheimer's — it's personal.

Stanford Economics BA + Data Science MS. Interned with Governor Newsom's Senior Advisor on Social Innovation. VP of Synapse (brain injury support). Olympic Trials Finalist in the 1500m. Stanford and Pac-12 record holder.

Stanford Computational Biology. Researched immune cell distribution and depression under Dr. Michael Snyder. Founded Steel Jupiter (EPA-approved air filter tech). Currently at Palantir.

Operational and creative anchor. Expertise in accounting, CRM, AI tools, and project management. First university council president at her university. Champions accessible education and marginalized communities.

Cornell University — Chemical and Biomolecular Engineering with Business minor. Prior experience at a biopharmaceutical company and LifeNome, a precision health startup.
Our advisory network includes pioneers in genomics, venture capital, institutional investing, and culture.

Led Stanford Genetics to #1 worldwide ranking in genomics. Pioneer of multi-omic longitudinal health profiling. Founded 20+ companies. Former Director of Yale Center for Genomics.

30+ years investing. 40+ unicorns, 10+ IPOs. Forbes Midas List 2016–17. At Founders Fund with Peter Thiel, turned $3M into >$180M (~60x).

Managed ~$50B at Wellcome Trust Investments. Assets grew from £13.5B to £35B. Annualized returns >10% over 20 years, 16.4% over five years.

Leading authority in digital medicine and medical VR. Co-founder of the International VR Health Association. Stanford Visiting Scholar.

C-suite at PayPal, eBay, and Sonos. Created billions in shareholder value. COO of 500 Startups. Co-founder of Practical Ventures.

Top investment platform for emerging managers. Selection Committee includes Hilton Foundation, Pivotal Ventures, YMCA, Babson Endowment.

Multi-platinum artist. "Wake Me Up" — 4B+ streams. Founder of Major Inc, a biotech drug development platform focused on cancer.

20+ years portfolio management. Focus on retirement assets for individuals with >$1B. CFA. Advocate for conscious capitalism.
80+ investments across 11 categories. >$200M in follow-on funding. 3 FDA clearances. A+ co-investors including Lux Capital, Muse Capital, Draper Associates, Boost VC, and more.
Neuromodulation headband that shapes brain waves for drug-free sleep on demand. Outperforms 5 of 6 Rx treatments. MIT/Ed Boyden.
Alzheimer's drug development — GSM-776890 and ACT-I repurposing platform. Dr. Rudy Tanzi, Harvard/MGH.
Engineered microbubbles that ferry therapeutics directly to target cells — activated on-demand by ultrasound. Precision drug delivery that breaks through biology's toughest barriers.
Non-invasive brain-computer interface that decodes motor intent directly from neural signals. First application: next-gen prosthetics controlled by the mind.
Expansion microscopy, optogenetics, and high-speed brain imaging for brain disease. Ed Boyden, MIT.
AI/neurotech replacing old brain tissue with synthetic lab-grown tissue from iPSCs. Blue Brain Project founder.
Long-acting shRNA therapeutics for chronic stress and neural dysregulation.
AI-driven prevention of neurodegenerative disease by tackling root causes of brain aging.
AI-powered eye-tracking infrastructure for AR/VR, automotive, and clinical health. Unlocks real-time attention, emotion, and cognitive performance data — fast, affordable, and massively scalable.
Clinical digital twins and health forecasts. Automates physical exams, catches undiagnosed cancer.
First FDA-cleared AI for breast calcification and heart-risk in mammograms. Live at SimonMed, Solis.
AI-driven photoacoustic imaging for cancer detection via ultrasound.
Breath-based multi-cancer detection combining canine olfaction with AI brain-computer interface.
Radiation-free, pain-free mammogram replacement. $6M government funding. Clinical study with Yale.
Blood-based ovarian cancer assay. FDA Breakthrough Device. Nobel laureate Randy Schekman on board.
Wearable patch + AI for self-breast exams.
Cloud-based MSaaS for dense breast tissue cancer detection. Mayo Clinic partnership.
At-home alcohol use disorder and addiction treatment. Treating alcohol use like a medical disease rather than simply a behavioral one. 86% success rate vs. 13% inpatient.
Gen-AI assistant for mental health clinicians. 3,000 clinicians onboarded. Tim Draper/Boost VC backed.
First digital platform for safely tapering psychiatric meds. Dr. Mark Horowitz, deprescribing pioneer.
VR meditation/mindfulness platform. VA running 8 clinical trials. Created by Guitar Hero veterans.
Rapid saliva-based cortisol biosensor for PTSD, addiction, stress. Won Google Pitching Competition.
Metabolic approach to depression, anxiety, bipolar, OCD. Dr. Shebani Sethi, Stanford Psychiatry.
Peer-to-peer cancer support network connecting patients with lived-experience peers at the moment of diagnosis. In active pilot with Kaiser Permanente.
Psychedelic-assisted medicine targeting addiction at its neurological root. A new clinical paradigm for one of behavioral health's most persistent and costly conditions.
Sperm sorting tech to prevent mutations without IVF/PGT screening. Accessible and affordable.
Menstrual blood test for fertility and uterine health markers. Currently in stealth.
Continuous, noninvasive hormone monitoring for women. Real-time hormonal intelligence powering personalized health, fertility, and wellness decisions.
Artificial womb science. YC founders and Harvard pioneer in genetics and molecular engineering.
Whole-genome health assessments of embryos for IVF embryo selection.
Smart cooling wearable + AI coach for menopause. Detects and relieves hot flashes instantly.
Subcutaneous drug delivery for at-home pain management. Omnibus patent on 100+ drugs.
Smart mat for diabetic foot ulcer detection.
Digital health platform for chronic conditions. NSF grant. Gates Scholar founder.
Virtual care for chronic pain/fibromyalgia. First FDA-cleared digital behavioral therapy.
YC-backed. Remote molecular/digital measurement + AI for Long Covid and ME/CFS.
Remote treatment monitoring AI for clinical trials and specialty therapeutics.
AI surgical performance evaluation — sensors, EEG, video, motion. Dr. Carla Pugh, Stanford General Surgeon.
Partners with patients to collect single cell molecular data, powering precision medicine.
At-home blood diagnostics with AI DNA computing.
AI precision health clinic for food allergies.
AI concierge medicine — lab, genetics, wearables. Draper/Boost VC backed.
YC-backed. At-home urine biomarker tests with AI diagnoses for UTIs, kidney, heart, diabetes.
AI-driven skincare personalized to skin microbiome. Custom phage therapy serums.
Non-invasive fluid management tech. Predicts acute heart failure 48-72 hrs ahead. 2 FDA 510(k)s.
LLM-powered microbiome analysis. Digital twin creates virtual microbiome for intervention testing.
ML on world's most comprehensive bio data. 200+ condition predictions, up to 40x better than current biomarkers.
Patented non-toxic molecular iodine solutions for healthcare, biosafety, and food processing.
Personalized cancer drug combos via AI/ML and patient genetic/tumor models.
AI-designed biomimicry baby bottle personalized to mother's shape. Reduces colic and latching issues.
Only scalable protein sequencing platform. NIH ($1.1M), NY Biodefense ($2.8M) customers.
Simultaneous DNA, RNA, and protein profiling in a single sequencing readout.
'CGT Nespresso Machine' — robotics/microfluidics to bring cell & gene therapy to any hospital.
Non-viral nanotech delivery for DNA, mRNA, and proteins. MD Anderson partnership.
AI cancer drug discovery using 3D cell shape biology. Dr. Chris Bakal, pioneer.
Longevity breakthrough — bioreactor-grown mitochondria transplants. Approaching Phase I.
Long-read single-cell sequencing platform delivering ultra-precise genomic resolution. Advised by Dr. George Church, Harvard.
Full-stack RNA design engine. Combines AI and purpose-built infrastructure to engineer high-performance RNA molecules for therapeutics, biomanufacturing, and emerging biotech.
Antibody screening at 100x lower cost, performed directly in human cells. Generates the large-scale, high-quality biological datasets needed to train next-generation AI drug discovery models.
Sauna, ice bath, breathwork studios. 5.0 rating, Forbes, Vogue coverage. Non-alcoholic social space.
AI voice companion for weight loss coaching. Backed by a16z, General Catalyst, Anne Wojcicki.
Alt-protein food tech. Industry-high margins, 90% lower R&D costs. Walmart Marketplace launch.
AI wellness platform by Equinox co-founder Lavinia Errico. Holistic fitness for women.
Clinically validated VR/MR platform reducing stress, anxiety, and pain in healthcare settings.
Restaurant-quality hospital food at scale. Patient satisfaction 9%→90% at Northwell Health.
AR glasses that display live captions and real-time translation — giving deaf and hard-of-hearing users seamless access to spoken conversation. Wearable inclusion, built for everyday life.
Eye-tracking for cognitive load and fatigue. Customers: NASA, MIT, NBA, MLB, Qualcomm.
FDA-cleared AI hearing aid. Best Buy, Costco, Mayo Clinic preferred OTC. Amy Li, founder.
First AI marketplace for biotech. Google collaboration. Democratizing drug discovery AI.
AI oral care mouthpiece + scanner.
Patented compression + resistance glove for hand health. Amazon, Walmart, VA Medical Centers.
Most private AI assistant — local model, personal data never leaves device. Health applications.
AI for postdoc grant writing. Revenue-generating 1 month post-launch, 150+ active users.
Robotic system for MRI/CT-guided biopsies and ablations with real-time needle control.
AI research assistant for experiment planning. Uses GenAI + RAG for research protocols.
Lab-on-a-chip — digital microfluidics automating bio experiments. 10-100x faster antibody screening.
AI-designed cellular drugs for biologics manufacturing. Boosts yield and consistency.
Modular programmable cells as biologic factories. Synthetic biology + AI for precision therapeutics.
3D bioprinting of functional tissue and organs with embedded reinforcing fibers.